There may be doom and gloom around the economy but one certainty is that we’re going to need water no matter what, which has contributed to water service provider Vysarn (ASX: VYS) reporting a big lift in earnings for FY24. For the year ending 30 June 2024, Vysarn reported revenue of $75.9 million, an increase
Read More
Cycliq (ASX: CYQ) has entered into a 10-year licence agreement with BeEmotion, formerly NVISO Group, to integrate AI technology into its Fly cameras and edge devices. Cycliq is an Australian company that manufactures innovative cycling safety products, including the Fly6 and Fly12 cameras, with a global presence and over 200k products shipped. Founded in 2009,
Read More
In a period marked by government initiatives aimed at making child care more affordable for families, nationwide operator G8 Education (ASX: GEM) has reported strong profit growth, benefiting from timely alignment between subsidy policies and the financial realities of child care services. For the Half Year ended 30 June 2024, G8 Education, which operates over
Read More
The XJO is expected to open higher this morning following a continued move higher in the U.S overnight. Their futures are flat. Yesterday we retraced from our lows, bolstered by positive U.S futures during our session to, finish marginally in the green. This morning we will continue that strength and open near 8,025, and if
Read More
Lynch Group Holdings (ASX: LGL), a wholesaler and grower of flowers and potted plants in Australia and China, reported modest revenue growth for FY24. Despite their strong performance in Australia, the Company faced challenges in China due to weaker consumer demand and price declines. The Company reported its full-year results for the 12 months ending
Read More
Pharmaceutical and consumer health company, Bioxyne (ASX: BXN) has become the first manufacturer in Australia to produce cannabis gummies under a Good Manufacturing Practice (GMP) licence. Through its subsidiary, Breathe Life Sciences (BLS), Bioxyne has completed the first commercial run of these pharmaceutical-grade edibles, taking an early position in Australia’s fast-evolving medicinal cannabis market where
Read More